Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-03-22 @ 1:35 PM
Study NCT ID:
NCT00596934
Status:
COMPLETED
Last Update Posted:
2017-11-24
First Post:
2008-01-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)
Sponsor:
Elif Oral
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
R03DK074488
Study Type:
NIH
Study Domain:
None
Study Link:
https://reporter.nih.gov/quickSearch/R03DK074488
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None